Caseware UK (AP4) 2024.0.164 2024.0.164 2025-03-312025-03-312024-04-01trueNo description of principal activity11falsefalse 04168834 2024-04-01 2025-03-31 04168834 2023-04-01 2024-03-31 04168834 2025-03-31 04168834 2024-03-31 04168834 c:Director1 2024-04-01 2025-03-31 04168834 c:EntityHasNeverTraded 2024-04-01 2025-03-31 04168834 c:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 04168834 c:FullAccounts 2024-04-01 2025-03-31 04168834 c:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 04168834 c:Micro-entities 2024-04-01 2025-03-31 04168834 d:PoundSterling 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure

Registered number: 04168834










MANGAL PHARMACY LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2025

 
MANGAL PHARMACY LIMITED
REGISTERED NUMBER: 04168834

STATEMENT OF FINANCIAL POSITION
AS AT 31 MARCH 2025

2025
2024
£
£


Current assets
2
2

Net current assets
 
 
2
 
 
2

Total assets less current liabilities
2
2


Net assets
2
2



Capital and reserves
2
2


Notes


General information

Mangal Pharmacy Limited is a private company limited by share capital, incorporated in England and Wales under registration number 04168834. The registered office of the company is situated at Level 5A, Maple House, 149 Tottenham Court Road, London, W1T 7NF. 


Average number of employees

The average monthly number of employees, including directors, during the year was 1 (2024 - 1).

The Company was entitled to exemption from audit under section 480 of the Companies Act 2006.

The members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared in accordance with the provisions applicable to entities subject to the micro-entities' regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 3 December 2025.




Alok Mangal
Director

Page 1